+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Drug Discovery Services Market by Process (Candidate Validation, Hit-to-Lead Identification, Lead Optimization), Drug Type (Biologics, Small Molecules), Service type, Therapeutic Area, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5146254
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Drug Discovery Services Market size was estimated at USD 21.77 billion in 2023, USD 24.79 billion in 2024, and is expected to grow at a CAGR of 14.37% to reach USD 55.75 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Discovery Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Discovery Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Services Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., Agilent Technologies, Inc., Aurigene Discovery Technologies, BellBrook Labs, BioAscent Discovery Ltd., Charles River Laboratories International, Inc., Domainex Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., IQVIA Inc, Jubilant Biosys Ltd., Labcorp Drug Development, Merck KGaA, Piramal Pharma Solutions, Proteros biostructures GmbH, Sai Life Sciences Limited, Schrödinger, Inc., Selvita S.A., Shanghai ChemPartner, Shanghai Medicilon, Inc., Symeres, Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific Inc., UCB S.A., Viva Biotech, and Wuxi Apptec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Process
    • Candidate Validation
    • Hit-to-Lead Identification
    • Lead Optimization
    • Target Selection
    • Target Validation
  • Drug Type
    • Biologics
    • Small Molecules
  • Service type
    • Biology Services
    • Chemistry Services
  • Therapeutic Area
    • Cardiovascular Diseases
    • Digestive System Diseases
    • Neurology
    • Oncology
  • End-user
    • Academic Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Drug Discovery Services Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Discovery Services Market?
  3. What are the technology trends and regulatory frameworks in the Drug Discovery Services Market?
  4. What is the market share of the leading vendors in the Drug Discovery Services Market?
  5. Which modes and strategic moves are suitable for entering the Drug Discovery Services Market?

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drug Discovery Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
5.1.1.3. Research on rare diseases and orphan drugs
5.1.2. Restraints
5.1.2.1. Expensive drug discovery and development
5.1.3. Opportunities
5.1.3.1. Development in the biologics and focus on drug discovery
5.1.3.2. Potential associated with expiry of patents
5.1.4. Challenges
5.1.4.1. Strict government rules for drug discovery and animal usage
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Drug Discovery Services Market, by Process
6.1. Introduction
6.2. Candidate Validation
6.3. Hit-to-Lead Identification
6.4. Lead Optimization
6.5. Target Selection
6.6. Target Validation
7. Drug Discovery Services Market, by Drug Type
7.1. Introduction
7.2. Biologics
7.3. Small Molecules
8. Drug Discovery Services Market, by Service type
8.1. Introduction
8.2. Biology Services
8.3. Chemistry Services
9. Drug Discovery Services Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Digestive System Diseases
9.4. Neurology
9.5. Oncology
10. Drug Discovery Services Market, by End-user
10.1. Introduction
10.2. Academic Institutes
10.3. Pharmaceutical & Biotechnology Companies
11. Americas Drug Discovery Services Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Drug Discovery Services Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Drug Discovery Services Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Aganitha AI Inc.
15.1.2. Agilent Technologies, Inc.
15.1.3. Aurigene Discovery Technologies
15.1.4. BellBrook Labs
15.1.5. BioAscent Discovery Ltd.
15.1.6. Charles River Laboratories International, Inc.
15.1.7. Domainex Ltd.
15.1.8. Enzo Life Sciences Inc.
15.1.9. Eurofins Scientific SE
15.1.10. Frontage Laboratories, Inc.
15.1.11. GenScript Biotech Corporation
15.1.12. Integrated DNA Technologies, Inc.
15.1.13. IQVIA Inc
15.1.14. Jubilant Biosys Ltd.
15.1.15. Labcorp Drug Development
15.1.16. Merck KGaA
15.1.17. Piramal Pharma Solutions
15.1.18. Proteros biostructures GmbH
15.1.19. Sai Life Sciences Limited
15.1.20. Schrödinger, Inc.
15.1.21. Selvita S.A.
15.1.22. Shanghai ChemPartner
15.1.23. Shanghai Medicilon, Inc.
15.1.24. Symeres
15.1.25. Syngene International Limited
15.1.26. TCG Lifesciences Pvt. Limited
15.1.27. Thermo Fisher Scientific Inc.
15.1.28. UCB S.A.
15.1.29. Viva Biotech
15.1.30. Wuxi Apptec
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
FIGURE 2. DRUG DISCOVERY SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG DISCOVERY SERVICES MARKET DYNAMICS
FIGURE 7. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 8. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 10. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 12. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 14. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Aganitha AI Inc.
  • Agilent Technologies, Inc.
  • Aurigene Discovery Technologies
  • BellBrook Labs
  • BioAscent Discovery Ltd.
  • Charles River Laboratories International, Inc.
  • Domainex Ltd.
  • Enzo Life Sciences Inc.
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • IQVIA Inc
  • Jubilant Biosys Ltd.
  • Labcorp Drug Development
  • Merck KGaA
  • Piramal Pharma Solutions
  • Proteros biostructures GmbH
  • Sai Life Sciences Limited
  • Schrödinger, Inc.
  • Selvita S.A.
  • Shanghai ChemPartner
  • Shanghai Medicilon, Inc.
  • Symeres
  • Syngene International Limited
  • TCG Lifesciences Pvt. Limited
  • Thermo Fisher Scientific Inc.
  • UCB S.A.
  • Viva Biotech
  • Wuxi Apptec

Methodology

Loading
LOADING...

Table Information